Novel Trial Design: CHIEF-HF.

Volume: 14, Issue: 3, Pages: 396 - 404
Published: Mar 16, 2021
Abstract
Background null The expense of clinical trials mandates new strategies to efficiently generate evidence and test novel therapies. In this context, we designed a decentralized, patient-centered randomized clinical trial leveraging mobile technologies, rather than in-person site visits, to test the efficacy of 12 weeks of canagliflozin for the treatment of heart failure, regardless of ejection fraction or diabetes status, on the reduction of heart...
Paper Fields
Paper Details
Title
Novel Trial Design: CHIEF-HF.
Published Date
Mar 16, 2021
Volume
14
Issue
3
Pages
396 - 404
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.